Loading…
CordenPharma announced a €900 million investment over three years to expand its peptide technology platform, including new facilities in the US and Europe and a GMP capacity expansion at its Frankfurt site. The Frankfurt expansion is expected to be operational in Q4 2024.
“On 16 July 2024 we announced our largest strategic investment to date to grow our Peptide technology platform with a committed spend of ~€900m over the next 3 years.”cordenpharma.com
Summarized from public sources; check the original articles before acting on it.